A trial investigating the effect of a sinus rinse in people with CF
Details
- Therapeutic approach
- Anti-Infective
- Trial status
- Closed with results Participating Centres
- Trials Tracker ID
- TT002111
- Last updated
- 29/09/2020
A pilot study investigating the effects of manuka honey sinus rinse on sino-nasal outcome test scores in people with CF.
Study detailsPeople with with CF often have bacterial infection in their air ways. There is great interest in the different types of bacteria found within these infections. This clinical trial looks at whether a novel sinus rinse device (that incorporates manuka honey) could help clear infection or reduce the amount and/or types of bacteria found within the upper airway. This study assesses the changes in the Sino-Nasal Outcome Test (SNOT-22) scores along with any changes in quality of life, before and after the use of a sinus rinse device for 30 days. In addition to this, the amount and types of bacteria found in nasal swabs, the sinus rinse solution, and sputum samples, before and after using the sinus rinse device will be investigated. Sputum samples will also be monitored for changes in composition before and after using the sinus rinse.
- Phase
- Not applicable
- Length of participation
- 4 months
- Recruitment target
- 30
- CF sponsor type
- Academic
Who can take part?
- Age range
- 18 years and older
- Including people
18 years or older
Chronic symptoms of rhinosinusitis according to the criteria of the European Position Paper on Rhinosinusitis
Scores greater or equal to 7 on their SNOT-22 questionnaire.- Excluding people
Previously tested positive for the bacteria Mycobacterium tuberculosis.
Currently using a nasal rinse protocol
Known allergy to bee products